Dr. Emmanuel During, MD

Dr. During practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. During's NPI, 1104110212, was assigned on June 6, 2011. Dr. During graduated from Louis Pasteur Univ- Fac Med Science in 2003. Dr. During holds New York license 316629.

Dr. During's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. During's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. During is also affiliated with Mount Sinai Beth Israel. The medical group on file is Mount Sinai Institute for Liver Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. During practices. Vendor and product names are available with a free account.

Neurology is Dr. During's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. During is board certified in sleep medicine by the American Board of Family Medicine. Dmand AI has Dr. During's licenses on file in 3 states: New York, Arizona and California.

Dmand AI lists hypersomnia, restless legs syndrome and sleep apnea among the conditions Dr. During treats.

CMS data shows 643 Medicare services from Dr. During across 5 procedure codes in 2024, for 180 Medicare patients. Medicare paid $43,998 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Dr. During in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. During's median patient age at 55, with 45% women.

In 2024, Dr. During wrote 365 Medicare Part D claims for 78 patients. 74% of them were for generic drugs. CMS names the drug for 272 of them, across 10 drugs with 11 or more claims each, at $47,343 in total drug cost. In 2023, CMS named 99 claims across 4 drugs.

Dr. During accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. During as offering telehealth. CMS counts 15 procedures of skin biopsy by Dr. During, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. During, published from 2022 to 2025. 2025 was the busiest year, with 2. The most frequent topics are REM Sleep Behavior Disorder, Parkinson Disease and Synucleinopathies. Dr. During's most frequent co-authors are Anahid Hekmat, MD, Emmanuel Jean-Marie Mignot, MD and Oliver Richard Sum-Ping, MD.

Dmand AI links Dr. During to 2 clinical trials. Conditions studied include Dermatitis, Atopic and Skin Diseases, Eczematous. Open Payments lists research payments to Dr. During that name 2 trials.

CMS Open Payments shows 4 general payments to Dr. During from 2 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Sanofi and Genzyme US Companies paid the most, $1,250. It also lists 33 research payments totaling $18,076 from 2021 to 2023, naming 2 clinical trials.

Dr. During graduated from Louis Pasteur Univ- Fac Med Science in 2003.

Dr. During is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.